Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Grant LR"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Bakary Diatta, Aminata Nakoulima, Marylin Madamet, Bruno Pradines, Rémy Amalvict, Silman Diawara, Bécaye Fall, Gora Lo, Mame Bou Kounta, Mamadou Wague Gueye, Khalifa Ababacar Wade, Raymond Bercion
Publikováno v:
Malaria Journal
Malaria Journal, BioMed Central, 2017, 16 (1), pp.118. ⟨10.1186/s12936-017-1773-4⟩
Malaria Journal, 2017, 16 (1), pp.118. ⟨10.1186/s12936-017-1773-4⟩
Malaria Journal, BioMed Central, 2017, 16 (1), pp.118. ⟨10.1186/s12936-017-1773-4⟩
Malaria Journal, 2017, 16 (1), pp.118. ⟨10.1186/s12936-017-1773-4⟩
International audience; Background: In response to increasing resistance to anti-malarial drugs, Senegal adopted artemisinin-based combination therapy ( ACT) as the first-line treatment for uncomplicated malaria in 2006. However, resistance of Plasmo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abd6bbbd24457b6e9e61acd5db6054ab
https://hal.archives-ouvertes.fr/hal-01521245/document
https://hal.archives-ouvertes.fr/hal-01521245/document
Autor:
Miyazaki T; Nagasaki University, Nagasaki, Japan.; Division of Respirology, Rheumatology, Infectious Diseases, and Neurology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan., van der Linden M; German Reference Laboratory for Streptococci, Department of Medical Microbiology, University Hospital RWTH, Aachen, Germany., Hirano K; Nagasaki University, Nagasaki, Japan.; National Center for Global Health and Medicine, Tokyo, Japan., Maeda T; Nagasaki University, Nagasaki, Japan., Kohno S; Nagasaki University, Nagasaki, Japan., Gonzalez EN; Pfizer Inc., Collegeville, PA, United States., Zhang P; Pfizer Inc., Collegeville, PA, United States., Isturiz RE; Pfizer Inc., Collegeville, PA, United States., Gray SL; Pfizer Inc., Collegeville, PA, United States., Grant LR; Pfizer Inc., Collegeville, PA, United States., Pride MW; Pfizer Inc., Pearl RiverNew York, NY, United States., Gessner BD; Pfizer Inc., Collegeville, PA, United States., Jodar L; Pfizer Inc., Collegeville, PA, United States., Arguedas AG; Pfizer Inc., Collegeville, PA, United States.
Publikováno v:
Frontiers in microbiology [Front Microbiol] 2024 Sep 24; Vol. 15, pp. 1458307. Date of Electronic Publication: 2024 Sep 24 (Print Publication: 2024).
Autor:
Qiu X; Center for Communicable Disease Dynamics, Department of Epidemiology, T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA., McGee L; Division of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Hammitt L; Center for Indigenous Health, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Grant LR; Center for Indigenous Health, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., O'Brien KL; Center for Indigenous Health, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Hanage WP; Center for Communicable Disease Dynamics, Department of Epidemiology, T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA., Lipsitch M; Center for Communicable Disease Dynamics, Department of Epidemiology, T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA.; Department of Immunology and Infectious Diseases, T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA.
Publikováno v:
MBio [mBio] 2024 Aug 29, pp. e0335523. Date of Electronic Publication: 2024 Aug 29.
Autor:
Lewnard JA; School of Public Health, University of California, Berkeley, Berkeley, California 94720, United States, Center for Computational Biology.; College of Statistics, Data Science, and Society, University of California, Berkeley, Berkeley, California 94720, United States.; Augmented Graduate Group in Computational Precision Health, University of California, Berkeley, Berkeley, California 94720, United States., Hong V; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California 91101, United States., Grant LR; Pfizer Vaccines, Collegeville, Pennsylvania 19426, United States., Ackerson BK; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California 91101, United States., Bruxvoort KJ; Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama 35233, United States., Pomichowski M; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California 91101, United States., Arguedas A; Pfizer Vaccines, Collegeville, Pennsylvania 19426, United States., Cané A; Pfizer Vaccines, Collegeville, Pennsylvania 19426, United States., Jodar L; Pfizer Vaccines, Collegeville, Pennsylvania 19426, United States., Gessner BD; Pfizer Vaccines, Collegeville, Pennsylvania 19426, United States., Tartof SY; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California 91101, United States.; Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California 91101, United States.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2024 Aug 05. Date of Electronic Publication: 2024 Aug 05.
Autor:
Grant LR; Vaccines and Antivirals, Pfizer Inc., Collegeville, PA, United States., Apodaca K; Vaccines and Antivirals, Pfizer Inc., Collegeville, PA, United States., Deshpande L; JMI Laboratories, North Liberty, IA, United States., Kimbrough JH; JMI Laboratories, North Liberty, IA, United States., Hayford K; Vaccines and Antivirals, Pfizer Inc., Collegeville, PA, United States., Yan Q; Vaccines and Antivirals, Pfizer Inc., Collegeville, PA, United States., Mendes R; JMI Laboratories, North Liberty, IA, United States., Cané A; Vaccines and Antivirals, Pfizer Inc., Collegeville, PA, United States., Gessner BD; Vaccines and Antivirals, Pfizer Inc., Collegeville, PA, United States., Arguedas A; Vaccines and Antivirals, Pfizer Inc., Collegeville, PA, United States.
Publikováno v:
Frontiers in pediatrics [Front Pediatr] 2024 Jul 15; Vol. 12, pp. 1383748. Date of Electronic Publication: 2024 Jul 15 (Print Publication: 2024).
Autor:
Grant LR; Lewis R. Grant, MS, is a Scientist, Research and Development, Clinical Research Group, Thermo Fisher Scientific, Richmond, VA.
Publikováno v:
Health security [Health Secur] 2024 Jun; Vol. 22 (3), pp. 263-269. Date of Electronic Publication: 2024 May 08.
Autor:
Grant LR; Medical Development and Scientific Clinical Affairs, Pfizer Vaccines, 500 Arcola Road, Collegeville, PA 19426, USA. Electronic address: lindsay.grant@pfizer.com., Hanquet G; P95 Epidemiology & Pharmacovigilance, Koning Leopold III-laan 1, 3001 Leuven, Belgium. Electronic address: germaine.hanquet@p-95.com., Sepúlveda-Pachón IT; P95 Epidemiology & Pharmacovigilance, Koning Leopold III-laan 1, 3001 Leuven, Belgium. Electronic address: ingrid.sepulveda@p-95.com., Theilacker C; Medical Development and Scientific Clinical Affairs, Pfizer Pharma GmbH, Berlin, Germany. Electronic address: christian.theilacker@pfizer.com., Baay M; P95 Epidemiology & Pharmacovigilance, Koning Leopold III-laan 1, 3001 Leuven, Belgium. Electronic address: marc.baay@p-95.com., Slack MPE; School of Medicine & Dentistry, Griffith University Gold Coast Campus, Parklands Drive, Southport, Queensland, QLD 4222, Australia. Electronic address: m.slack@griffith.edu.au., Jodar L; Medical Development and Scientific Clinical Affairs, Pfizer Vaccines, 500 Arcola Road, Collegeville, PA 19426, USA. Electronic address: luis.jodar@pfizer.com., Gessner BD; Medical Development and Scientific Clinical Affairs, Pfizer Vaccines, 500 Arcola Road, Collegeville, PA 19426, USA. Electronic address: bradford.gessner@pfizer.com.
Publikováno v:
Vaccine [Vaccine] 2024 Apr 30; Vol. 42 (12), pp. 2983-2993. Date of Electronic Publication: 2024 Mar 28.